Various postulations are reported explaining this survival benefit and one such hypothesis is silencing of MGMT gene induced by the “glioma-CpG island methylator phenotype [81] (G-CIMP)” induced by mutant IDH [82,83,84,85,86] though another report contradicted the same [69]. The gene discussed is IDH2; the disease is glioma.